Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation
Article
Kolijn, Detmar, Pabel, Steffen, Tian, Yanna, Lódi, Mária
, Herwig, Melissa
, Carrizzo, Albino
, Zhazykbayeva, Saltanat, Kovács, Árpád, Fülöp, Gábor Á., Falcão-Pires, Inês, Reusch, Peter H., Linthout, Sophie Van, Papp, Zoltán, van Heerebeek, Loek, Vecchione, Carmine, Maier, Lars S.
, Ciccarelli, Michele
, Tschöpe, Carsten, Mügge, Andreas, Bagi, Zsolt, Sossalla, Samuel and Hamdani, Nazha
(2020)
Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation.
Cardiovascular Research 117 (2), pp. 495-507.
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Cardiovascular Research | ||||
| Publisher | Oxford Univ. Press | ||||
| Place of Publication | OXFORD | ||||
| Volume | 117 | ||||
| Number of Issue or Book Chapter | 2 | ||||
| Page Range | pp. 495-507 | ||||
| Date | 2020 | ||||
| Date of publication | 29 Feb 2024 12:35 | ||||
| Institutions | Medicine > Lehrstuhl für Innere Medizin II | ||||
| Identification Number |
| ||||
| Keywords | Empagliflozin; HFpEF; PKG; Diastolic function; Oxidative stress | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Partially | ||||
| Item ID | 56672 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric